{"organizations": [], "uuid": "d458bf769c059169e685fcf139735cd560330a4a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/personal-finance/analyst-research", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "https://www.reuters.com/article/brief-recro-pharma-inc-reports-year-end/brief-recro-pharma-inc-reports-year-end-2017-financial-results-idUSASB0C7NQ", "country": "US", "domain_rank": 408, "title": "BRIEF-Recro Pharma Inc Reports Year End 2017 Financial Results", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.439, "site_type": "news", "published": "2018-02-27T20:09:00.000+02:00", "replies_count": 0, "uuid": "d458bf769c059169e685fcf139735cd560330a4a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-recro-pharma-inc-reports-year-end/brief-recro-pharma-inc-reports-year-end-2017-financial-results-idUSASB0C7NQ", "ord_in_thread": 0, "title": "BRIEF-Recro Pharma Inc Reports Year End 2017 Financial Results", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "recro pharma inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-recro pharma inc", "sentiment": "negative"}, {"name": "nda", "sentiment": "none"}, {"name": "pdufa", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Recro Pharma Inc:\n* RECRO PHARMA REPORTS YEAR END 2017 FINANCIAL RESULTS * RECRO PHARMA INC - FOR 2018, COMPANY EXPECTS REVENUE GENERATED FROM ITS CDMO DIVISION TO BE APPROXIMATELY $70 MILLION\n* RECRO PHARMA INC - IV MELOXICAM NDA SUBMITTED AND PDUFA ACTION DATE SET FOR MAY 26, 2018 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T20:09:00.000+02:00", "crawled": "2018-02-27T14:11:59.028+02:00", "highlightTitle": ""}